Short Interest in Masimo Co. (MASI) Decreases By 26.3%

Masimo Co. (NASDAQ:MASI) was the recipient of a significant decline in short interest in the month of January. As of January 12th, there was short interest totalling 876,332 shares, a decline of 26.3% from the December 29th total of 1,189,834 shares. Based on an average trading volume of 463,935 shares, the short-interest ratio is presently 1.9 days. Currently, 1.8% of the shares of the company are sold short.

In related news, EVP Yongsam Lee sold 5,000 shares of the business’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $89.89, for a total transaction of $449,450.00. Following the transaction, the executive vice president now directly owns 74,000 shares in the company, valued at $6,651,860. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Steven Barker sold 10,000 shares of the business’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $90.00, for a total value of $900,000.00. Following the transaction, the director now owns 73,249 shares in the company, valued at $6,592,410. The disclosure for this sale can be found here. Insiders have sold 65,074 shares of company stock worth $5,798,945 over the last 90 days. Corporate insiders own 16.60% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in the company. DekaBank Deutsche Girozentrale grew its position in Masimo by 78.3% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 2,106 shares of the medical equipment provider’s stock worth $182,000 after acquiring an additional 925 shares during the last quarter. Advisor Group Inc. grew its position in Masimo by 38.4% during the 2nd quarter. Advisor Group Inc. now owns 2,361 shares of the medical equipment provider’s stock worth $216,000 after acquiring an additional 655 shares during the last quarter. Intellectus Partners LLC bought a new stake in Masimo during the 2nd quarter worth approximately $237,000. Shelton Capital Management bought a new stake in Masimo during the 2nd quarter worth approximately $269,000. Finally, Jane Street Group LLC bought a new stake in Masimo during the 3rd quarter worth approximately $317,000. Institutional investors own 83.64% of the company’s stock.

Several brokerages recently issued reports on MASI. Zacks Investment Research lowered Masimo from a “buy” rating to a “hold” rating in a research note on Wednesday, January 3rd. BidaskClub lowered Masimo from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $108.00 price objective on shares of Masimo in a research note on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $97.17.

Shares of Masimo (MASI) opened at $91.54 on Monday. Masimo has a 12 month low of $71.15 and a 12 month high of $104.71. The firm has a market capitalization of $4,730.00, a P/E ratio of 14.51, a PEG ratio of 3.49 and a beta of 0.72.

Masimo (NASDAQ:MASI) last released its quarterly earnings data on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.17. Masimo had a return on equity of 22.17% and a net margin of 45.83%. The company had revenue of $193.69 million for the quarter, compared to analyst estimates of $189.01 million. During the same period in the prior year, the company posted $0.52 EPS. The company’s revenue was up 15.6% compared to the same quarter last year. equities analysts expect that Masimo will post 2.95 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This piece of content was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2018/01/29/short-interest-in-masimo-co-masi-decreases-by-26-3.html.

About Masimo

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply